Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity.

Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity. Abstract Text:

    yan-fei xinYan-Fei Xin,guo-liang zhouGuo-Liang Zhou,min shenMin Shen,yun-xiang chenYun-Xiang Chen,shu-peng liuShu-Peng Liu,guo-chan chenGuo-Chan Chen,hao chenHao Chen,zhen-qiang youZhen-Qiang You,yao-xian xuanYao-Xian Xuan,yan-fei xinYan-Fei Xin,guo-liang zhouGuo-Liang Zhou,min shenMin Shen,yun-xiang chenYun-Xiang Chen,shu-peng liuShu-Peng Liu,guo-chan chenGuo-Chan Chen,hao chenHao Chen,zhen-qiang youZhen-Qiang You,yao-xian xuanYao-Xian Xuan,yan-fei xinYan-Fei Xin,guo-liang zhouGuo-Liang Zhou,min shenMin Shen,yun-xiang chenYun-Xiang Chen,shu-peng liuShu-Peng Liu,guo-chan chenGuo-Chan Chen,hao chenHao Chen,zhen-qiang youZhen-Qiang You,yao-xian xuanYao-Xian Xuan,

    Doxorubicin is an anthracycline antibiotic agent used in the treatment of a variety of solid and haematopoietic tumours, but its use is limited by formation of metabolites that induce acute and chronic cardiac toxicities. Angelica sinensis has been widely used to treat cardiovascular and cerebrovascular diseases in China. In the present study, we used an in vivo mouse model to explore whether A. sinensis could protect against doxorubicin-induced chronic cardiotoxicity. Male ICR mice were treated with distilled water or water extraction of A. sinensis (15 g/kg, orally) daily for 4 weeks, followed by saline or doxorubicin (15 mg/kg, intravenously) treatments weekly. Cardiotoxicity was assessed by electrocardiograph, antioxidant activity in cardiac tissues, serum levels of creatine kinase, aspartate aminotransferase (AST) and histopathological change in cardiac tissues. A cumulative dose of doxorubicin (60 mg/kg) caused animal death and myocardial injury characterized by increased QT interval and decreased heart rate in electrocardiograph, decrease of heart antioxidant activity, increase of serum AST, as well as myocardial lesions. Pre-treatment with A. sinensis significantly reduced mortality and improved heart performance of the doxorubicin-treated mice as evidenced from normalization of antioxidative activity and serum AST, preventing loss of myofibrils as well as improving arrhythmias and conduction abnormalities. Furthermore, the in vitro cytotoxic study showed that A. sinensis did not compromise the antitumour activity of doxorubicin. These results suggested that A. sinensis elicited a typical cardioprotective effect on doxorubicin-related oxidative stress, and could be a novel adjunct in the combination with doxorubicin chemotherapy.

    Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity. Publishing Authors By Initials

    yf xinYF Xin,gl zhouGL Zhou,m shenM Shen,yx chenYX Chen,sp liuSP Liu,gc chenGC Chen,h chenH Chen,zq youZQ You,yx xuanYX Xuan,yf xinYF Xin,gl zhouGL Zhou,m shenM Shen,yx chenYX Chen,sp liuSP Liu,gc chenGC Chen,h chenH Chen,zq youZQ You,yx xuanYX Xuan,yf xinYF Xin,gl zhouGL Zhou,m shenM Shen,yx chenYX Chen,sp liuSP Liu,gc chenGC Chen,h chenH Chen,zq youZQ You,yx xuanYX Xuan,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Basic & clinical pharmacology & toxicology

    VOLUME: 101

    Page Numbers: 421-6

    Journal Abbreviation: Basic Clin. Pharmacol. Toxicol

    ISSN: 1742-7835

    DAY: 25

    MONTH: 10

    YEAR: 2007

    Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101208422

    Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity.

    AFFILIATION: State Key Laboratory of Safety Evaluation for New Drugs, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, China.

    Country: Denmark

    Denmark Research PublicationDenmark Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Basic Clin Pharmacol Toxicol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News